First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009.
about
Resource-Stratified Guidelines for Cancer Management: Correction and CommentaryDifferences in outcome and toxicity between Asian and caucasian patients with lung cancer treated with systemic therapy.Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance.Global cancer consortiums: moving from consensus to practice.A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancer.
P2860
First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
First-line systemic treatment ...... he Asian Oncology Summit 2009.
@en
First-line systemic treatment ...... he Asian Oncology Summit 2009.
@nl
type
label
First-line systemic treatment ...... he Asian Oncology Summit 2009.
@en
First-line systemic treatment ...... he Asian Oncology Summit 2009.
@nl
prefLabel
First-line systemic treatment ...... he Asian Oncology Summit 2009.
@en
First-line systemic treatment ...... he Asian Oncology Summit 2009.
@nl
P2093
P50
P1433
P1476
First-line systemic treatment ...... the Asian Oncology Summit 2009
@en
P2093
Asian Oncology Summit
Benjamin O Anderson
Chih-Hsin Yang
Meilin Liao
Peter Goldstraw
Ross A Soo
P304
P356
10.1016/S1470-2045(09)70238-4
P577
2009-11-01T00:00:00Z